Drug recall · March 25, 2015
RIFAMPIN for Injection recall
Why: Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31
- Lots / codes
Lot # VRIA002; Exp. 08/16, VRIA003; Exp. 09/16, VRIA004; Exp. 09/16
- Quantity
- 24,344 vials
- Company
- Heritage Pharmaceuticals, Inc., Eatontown, NJ
- Distribution
- Nationwide
- Initiated
- February 25, 2015 · Voluntary: Firm initiated
- Classified
- March 17, 2015
- Reported
- March 25, 2015
- Ended
- February 26, 2016
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rifampin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.